Hidradenitis suppurativa - Hidradenit Suppurativa
☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Hidradenit Suppurativa (Hidradenitis suppurativa) (etap I) nan anbabra a. Sa a se yon ka trè modere nan Hidradenit Suppurativa (Hidradenitis suppurativa).
References
Hidradenitis suppurativa se yon maladi po ki kwonik, ki kontinye ap retounen, epi ki ka afekte lavi ou seryezman. Li koze pa enflamasyon nan folikulèr cheve yo, epi li souvan mennen nan enfeksyon bakteri. Doktè yo anjeneral fè dyagnostik li lè yo gade kalite maleng ou genyen (tankou nodil, absè, oswa kannal sinis) , kote yo ye (anjeneral nan pli po) , ak konbyen fwa yo retounen ak konbyen tan yo kole.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Tretman ki pa byolojik ak ki pa pwosedi yo souvan itilize pou kont maladi grav epi yo ka konbine avèk terapi byolojik ak operasyon pou maladi modere ak grav. Etid resan yo bay plis prèv ki montre efikasite pou itilize kortikoterapi sou fòm piki dirèkteman nan blesi yo pou flare-ups HS ak blesi lokalize. Anplis de sa, gen prèv ki sijere ke lè l sèvi avèk tetracyclines pou kont li ka menm jan ak konbine clindamycin ak rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Anpil tretman yo itilize pou hidradenitis suppurativa, ki gen ladan antibyotik, retinoid, antiandrojèn, dwòg iminitè-siprime, medikaman anti-enflamatwa, ak radyoterapi pou blesi bonè. Tretman ki pi gwo rekòmande yo se adalimumab ak terapi lazè. Operasyon, swa eksizyon senp oswa eksizyon lokal konplè ak grèf po, se opsyon ki pi pito pou ka grav, avanse ki pa byen reponn ak lòt tretman.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Kòz egzak la anjeneral klè, men yo kwè ke yo enplike yon konbinezon de faktè jenetik ak anviwònman an. Apeprè yon tyè nan moun ki gen maladi a gen yon manm fanmi ki afekte. Lòt faktè risk yo enkli obezite ak fimen. Kondisyon an pa koze pa yon enfeksyon, move ijyèn.
Pa gen gerizon li te ye. Koupe louvri blesi yo pou pèmèt yo drenaj pa lakòz benefis enpòtan. Pandan ke antibyotik yo souvan itilize, prèv pou itilizasyon yo se pòv. Yo ka eseye tou medikaman imunosuppressive. Nan moun ki gen maladi ki pi grav, terapi lazè oswa operasyon pou retire po ki afekte a ka solid. Raman, yon blesi po ka devlope nan kansè po.
Si yo enkli ka modere hidradenit suppurativa (hidradenitis suppurativa) , lè sa a estimasyon frekans li yo soti nan 1-4% nan popilasyon an. Fanm gen twa fwa plis chans pou yo dyagnostike ak li pase gason. Aparisyon se tipikman nan jèn adilt.